IREDEX Ophthalmology Revenues Up to $9.2M in 4Q

IREDEX, laser-based medical systems developer and manufacturer, has announced that its ophthalmology revenues in the fourth quarter of 2012 were $9.2 million, up from $8.6 million in the fourth quarter of 2011, a nearly 7 percent increase, according to a Daily Markets report.

Advertisement
Carrie Pallardy

Ophthalmology revenues in the fourth quarter of 2012 were a record high for the Mountain View, Calif.-based IREDEX.

More Articles on Ophthalmology:
NY Vision Group Opens Tribeca Location
Transcend Medical Joins COMPASS Clinical Study to Assess CyPass Micro-Stent
Ocular Therapeutix Seeking FDA Approval for ReSure Sealant

Shared risk, shared data: What leaders say is really driving payer-provider alignment

Recommended Whitepaper

Advertisement

Next Up in Ophthalmology

Advertisement

Comments are closed.